Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Methylprednisolone × 1 year × Clear all

Sponsor

Conditions

Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 3 Lymphoma, Follicular 3 Leukemia, Biphenotypic, Acute 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hematologic Neoplasms 2 Drug-Related Side Effects and Adverse Reactions 2 Skin Neoplasms 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Melanoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Down Syndrome 1 Cranial Nerve Diseases 1 Colitis 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Biopsy 5 ulixertinib 2 trametinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 tazemetostat 1 palbociclib 1 olaparib 1 etoposide phosphate 1 cobimetinib 1 Vemurafenib 1 Sirolimus 1 Pharmacogenomic Variants 1 Lenalidomide 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡